PET Groups Carp On CMS Coverage Policy, National Coverage Decision Delay
This article was originally published in The Gray Sheet
Executive Summary
CMS' cautious approach to covering positron emission tomography indications has spurred criticism among the PET industry, which seeks to accelerate reimbursement to drive the technology's adoption